| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 25,499 | 23,082 | 20,583 | 21,495 | | Cost of Revenue | 15,691 | 11,676 | 11,855 | 15,630 | | | Gross Profit | 9,808 | 11,406 | 8,728 | 5,865 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 310 | 3,749 | 3,640 | (649) | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 2,174 | 2,110 | 2,086 | 2,050 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 7,324 | 5,547 | 3,002 | 4,464 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (81) | 383 | 409 | 358 | | Earnings Before Interest And Taxes | 7,243 | 5,930 | 3,411 | 4,822 | | Interest Expense | 1,064 | 1,766 | 1,392 | 1,896 | | Income Before Tax | 6,179 | 4,164 | 2,019 | 2,926 | | Income Tax Expense | 2,152 | 1,318 | 658 | 1,002 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 4,027 | 2,846 | 1,361 | 1,924 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 4,027 | 2,846 | 1,361 | 1,924 | | Preferred Stock And Other Adjustments | (52) | (52) | (52) | (52) | | | Net Income Applicable To Common Shares | $3,975 | $2,794 | $1,309 | $1,872 |
|
0.41% Nasdaq 
Income Statement
